Literature DB >> 6721815

Effects of extended hypoxia on night vision.

J L Kobrick, H Zwick, C E Witt, J A Devine.   

Abstract

The effects of 16 d of sustained hypoxia (4300-m equivalent) on the dark adaptation threshold function were studied in 12 male subjects measured periodically (days 2,4,6,9,11,13,16 of exposure) over a 20-min test period for both red and green stimuli using a new computerized dark adaptometer. Comparison with sea level performance showed negligible elevations of thresholds for red response, but highly significant impairment of green response (p less than 0.00001) over almost the entire dark adaptation function. These losses peaked between the sixth and ninth day followed by little recovery, except at the eleventh day when the subjects descended briefly to 3200 m elevation. Impairments developed rapidly again upon return to the original higher altitude. The results differ from previous findings after shorter exposure periods, which showed only slight impairments of the early segment of dark adaptation. Implications of the results are discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6721815

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  4 in total

Review 1.  Neuropsychological functioning associated with high-altitude exposure.

Authors:  Javier Virués-Ortega; Gualberto Buela-Casal; Eduardo Garrido; Bernardino Alcázar
Journal:  Neuropsychol Rev       Date:  2004-12       Impact factor: 7.444

Review 2.  Effects of altitude on mood, behaviour and cognitive functioning. A review.

Authors:  M S Bahrke; B Shukitt-Hale
Journal:  Sports Med       Date:  1993-08       Impact factor: 11.136

3.  Chronic intermittent hypoxia impacts the olfactory nervous system in an age-dependent manner: pilot study.

Authors:  Boo-Young Kim; Sang Haak Lee; In Kyoung Kim; Ju Yeon Park; Jung Ho Bae
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-02       Impact factor: 2.503

4.  The effect of a moderate level of hypoxia on human color vision.

Authors:  A J Vingrys; L F Garner
Journal:  Doc Ophthalmol       Date:  1987-06       Impact factor: 2.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.